Novo Nordisk A/S ADR buy TD Cowen
Start price
19.08.25
/
50%
€47.20
Target price
19.08.26
€60.08
Performance (%)
-21.06%
Price
05.06.26
€37.26
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.06%. This prediction currently runs until 19.08.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -4.657% | -4.657% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at TD Cowen from $105.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24
